Copyright Reports & Markets. All rights reserved.

Global Immunotherapy Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Immunotherapy

      • 1.1 Definition of Immunotherapy
      • 1.2 Immunotherapy Segment by Type
        • 1.2.1 Global Immunotherapy Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Monoclonal Antibodies
        • 1.2.3 Therapeutic Vaccines
        • 1.2.4 Checkpoint Inhibitors
        • 1.2.5 Non-Specific Immunotherapy
      • 1.3 Immunotherapy Segment by Applications
        • 1.3.1 Global Immunotherapy Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Oncology
        • 1.3.3 Inflammation
        • 1.3.4 Central Nervous System
        • 1.3.5 Others
      • 1.4 Global Immunotherapy Overall Market
        • 1.4.1 Global Immunotherapy Revenue (2014-2025)
        • 1.4.2 Global Immunotherapy Production (2014-2025)
        • 1.4.3 North America Immunotherapy Status and Prospect (2014-2025)
        • 1.4.4 Europe Immunotherapy Status and Prospect (2014-2025)
        • 1.4.5 China Immunotherapy Status and Prospect (2014-2025)
        • 1.4.6 Japan Immunotherapy Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Immunotherapy Status and Prospect (2014-2025)
        • 1.4.8 India Immunotherapy Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Immunotherapy
      • 2.3 Manufacturing Process Analysis of Immunotherapy
      • 2.4 Industry Chain Structure of Immunotherapy

      3 Development and Manufacturing Plants Analysis of Immunotherapy

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Immunotherapy Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Immunotherapy
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Immunotherapy Production and Capacity Analysis
      • 4.2 Immunotherapy Revenue Analysis
      • 4.3 Immunotherapy Price Analysis
      • 4.4 Market Concentration Degree

      5 Immunotherapy Regional Market Analysis

      • 5.1 Immunotherapy Production by Regions
        • 5.1.1 Global Immunotherapy Production by Regions
        • 5.1.2 Global Immunotherapy Revenue by Regions
      • 5.2 Immunotherapy Consumption by Regions
      • 5.3 North America Immunotherapy Market Analysis
        • 5.3.1 North America Immunotherapy Production
        • 5.3.2 North America Immunotherapy Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Immunotherapy Import and Export
      • 5.4 Europe Immunotherapy Market Analysis
        • 5.4.1 Europe Immunotherapy Production
        • 5.4.2 Europe Immunotherapy Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Immunotherapy Import and Export
      • 5.5 China Immunotherapy Market Analysis
        • 5.5.1 China Immunotherapy Production
        • 5.5.2 China Immunotherapy Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Immunotherapy Import and Export
      • 5.6 Japan Immunotherapy Market Analysis
        • 5.6.1 Japan Immunotherapy Production
        • 5.6.2 Japan Immunotherapy Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Immunotherapy Import and Export
      • 5.7 Southeast Asia Immunotherapy Market Analysis
        • 5.7.1 Southeast Asia Immunotherapy Production
        • 5.7.2 Southeast Asia Immunotherapy Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Immunotherapy Import and Export
      • 5.8 India Immunotherapy Market Analysis
        • 5.8.1 India Immunotherapy Production
        • 5.8.2 India Immunotherapy Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Immunotherapy Import and Export

      6 Immunotherapy Segment Market Analysis (by Type)

      • 6.1 Global Immunotherapy Production by Type
      • 6.2 Global Immunotherapy Revenue by Type
      • 6.3 Immunotherapy Price by Type

      7 Immunotherapy Segment Market Analysis (by Application)

      • 7.1 Global Immunotherapy Consumption by Application
      • 7.2 Global Immunotherapy Consumption Market Share by Application (2014-2019)

      8 Immunotherapy Major Manufacturers Analysis

      • 8.1 Abbvie
        • 8.1.1 Abbvie Immunotherapy Production Sites and Area Served
        • 8.1.2 Abbvie Product Introduction, Application and Specification
        • 8.1.3 Abbvie Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Amgen, Inc.
        • 8.2.1 Amgen, Inc. Immunotherapy Production Sites and Area Served
        • 8.2.2 Amgen, Inc. Product Introduction, Application and Specification
        • 8.2.3 Amgen, Inc. Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Biogen
        • 8.3.1 Biogen Immunotherapy Production Sites and Area Served
        • 8.3.2 Biogen Product Introduction, Application and Specification
        • 8.3.3 Biogen Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Bristol-Myers Squibb
        • 8.4.1 Bristol-Myers Squibb Immunotherapy Production Sites and Area Served
        • 8.4.2 Bristol-Myers Squibb Product Introduction, Application and Specification
        • 8.4.3 Bristol-Myers Squibb Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Celgene
        • 8.5.1 Celgene Immunotherapy Production Sites and Area Served
        • 8.5.2 Celgene Product Introduction, Application and Specification
        • 8.5.3 Celgene Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Johnson & Johnson
        • 8.6.1 Johnson & Johnson Immunotherapy Production Sites and Area Served
        • 8.6.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.6.3 Johnson & Johnson Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Merck
        • 8.7.1 Merck Immunotherapy Production Sites and Area Served
        • 8.7.2 Merck Product Introduction, Application and Specification
        • 8.7.3 Merck Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Novartis
        • 8.8.1 Novartis Immunotherapy Production Sites and Area Served
        • 8.8.2 Novartis Product Introduction, Application and Specification
        • 8.8.3 Novartis Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Pfizer
        • 8.9.1 Pfizer Immunotherapy Production Sites and Area Served
        • 8.9.2 Pfizer Product Introduction, Application and Specification
        • 8.9.3 Pfizer Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Roche
        • 8.10.1 Roche Immunotherapy Production Sites and Area Served
        • 8.10.2 Roche Product Introduction, Application and Specification
        • 8.10.3 Roche Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Immunotherapy Market

      • 9.1 Global Immunotherapy Market Trend Analysis
        • 9.1.1 Global Immunotherapy Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Immunotherapy Regional Market Trend
        • 9.2.1 North America Immunotherapy Forecast 2019-2025
        • 9.2.2 Europe Immunotherapy Forecast 2019-2025
        • 9.2.3 China Immunotherapy Forecast 2019-2025
        • 9.2.4 Japan Immunotherapy Forecast 2019-2025
        • 9.2.5 Southeast Asia Immunotherapy Forecast 2019-2025
        • 9.2.6 India Immunotherapy Forecast 2019-2025
      • 9.3 Immunotherapy Market Trend (Product Type)
      • 9.4 Immunotherapy Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Immunotherapy Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Immunotherapy is the treatment given to suppress or amplify the immune response of a person using immunomodulators. The amplification of immune response is called as activation immunotherapy and the suppression of the immune response is called suppression immunotherapy.

        The global Immunotherapy market was valued at 106900 million US$ in 2018 and will reach 179100 million US$ by the end of 2025, growing at a CAGR of 6.7% during 2019-2025.
        This report focuses on Immunotherapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Immunotherapy market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Immunotherapy in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Immunotherapy manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Abbvie
        Amgen, Inc.
        Biogen
        Bristol-Myers Squibb
        Celgene
        Johnson & Johnson
        Merck
        Novartis
        Pfizer
        Roche

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Monoclonal Antibodies
        Therapeutic Vaccines
        Checkpoint Inhibitors
        Non-Specific Immunotherapy

        Segment by Application
        Oncology
        Inflammation
        Central Nervous System
        Others

        Buy now